262 related articles for article (PubMed ID: 28451824)
1. Heart Failure Guidelines on Pharmacotherapy.
Papadimitriou L; Hamo CE; Butler J
Handb Exp Pharmacol; 2017; 243():109-129. PubMed ID: 28451824
[TBL] [Abstract][Full Text] [Related]
2. An evidence-based review of recent advances in therapy for heart failure with reduced ejection fraction (HFrEF).
Raj L; Adhyaru B
Postgrad Med J; 2016 Dec; 92(1094):726-734. PubMed ID: 27708003
[TBL] [Abstract][Full Text] [Related]
3. Heart Failure Update: Outpatient Management.
Wojnowich K; Korabathina R
FP Essent; 2016 Mar; 442():18-25. PubMed ID: 26974001
[TBL] [Abstract][Full Text] [Related]
4. Medical therapy of heart failure with reduced ejection fraction: current evidence and new developments.
Naegele M; Flammer AJ; Enseleit F; Ruschitzka F
Swiss Med Wkly; 2016; 146():w14295. PubMed ID: 26968014
[TBL] [Abstract][Full Text] [Related]
5. A Review of New Pharmacologic Treatments for Patients With Chronic Heart Failure With Reduced Ejection Fraction.
Nguyen E; Weeda ER; White CM
J Clin Pharmacol; 2016 Aug; 56(8):936-47. PubMed ID: 26626162
[TBL] [Abstract][Full Text] [Related]
6. [Pharmacological therapy of heart failure with reduced ejection fraction].
Wieser M; Rhyner D; Martinelli M; Suter T; Schnegg B; Bösch C; Wigger O; Dobner S; Hunziker L
Ther Umsch; 2018 Sep; 75(3):180-186. PubMed ID: 30145973
[TBL] [Abstract][Full Text] [Related]
7. Comments on the 2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure.
Sionis A; ; Sionis Green A; Manito Lorite N; Bueno H; Coca Payeras A; Díaz Molina B; González Juanatey JR; Ruilope Urioste LM; Zamorano Gómez JL; ; Almenar Bonet L; Ariza Solé A; Bover Freire R; Lambert Rodríguez JL; López de Sá E; López Fernández S; Martín Asenjo R; Mirabet Pérez S; Pascual Figal D; Segovia Cubero J; Varela Román A; ; San Román Calvar JA; Alfonso Manterola F; Arribas Ynsaurriaga F; Evangelista Masip A; Ferreira González I; Jiménez Navarro M; Marin Ortuño F; Pérez de Isla L; Rodríguez Padial L; Sánchez Fernández PL; Sionis Green A; Vázquez García R
Rev Esp Cardiol (Engl Ed); 2016 Dec; 69(12):1119-1125. PubMed ID: 27894486
[No Abstract] [Full Text] [Related]
8. Background pharmacological therapy in the ANTHEM-HF: comparison to contemporary trials of novel heart failure therapies.
Premchand RK; Sharma K; Mittal S; Monteiro R; Libbus I; Ardell JL; Gregory DD; KenKnight BH; Amurthur B; DiCarlo LA; Anand IS
ESC Heart Fail; 2019 Oct; 6(5):1052-1056. PubMed ID: 31339232
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological management of chronic heart failure: old drugs, new drugs and new indications.
Lim WY; Woldman S
Br J Hosp Med (Lond); 2013 Feb; 74(2):C18-22. PubMed ID: 23411909
[No Abstract] [Full Text] [Related]
10. Neprilysin Inhibitors in Cardiovascular Disease.
Kang G; Banerjee D
Curr Cardiol Rep; 2017 Feb; 19(2):16. PubMed ID: 28185171
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Quality of Care for US Veterans With Recent-Onset Heart Failure With Reduced Ejection Fraction.
Sandhu AT; Kohsaka S; Turakhia MP; Lewis EF; Heidenreich PA
JAMA Cardiol; 2022 Feb; 7(2):130-139. PubMed ID: 34757380
[TBL] [Abstract][Full Text] [Related]
12. Evolving therapies for the management of chronic and acute decompensated heart failure.
Cook JC; Tran RH; Patterson JH; Rodgers JE
Am J Health Syst Pharm; 2016 Nov; 73(21):1745-1754. PubMed ID: 27769970
[TBL] [Abstract][Full Text] [Related]
13. Ivabradine and outcomes in chronic heart failure.
Gupta A; Sharma YP
Lancet; 2010 Dec; 376(9758):2069; author reply 2069-70. PubMed ID: 21168044
[No Abstract] [Full Text] [Related]
14. Estimated 5-Year Number Needed to Treat to Prevent Cardiovascular Death or Heart Failure Hospitalization With Angiotensin Receptor-Neprilysin Inhibition vs Standard Therapy for Patients With Heart Failure With Reduced Ejection Fraction: An Analysis of Data From the PARADIGM-HF Trial.
Srivastava PK; Claggett BL; Solomon SD; McMurray JJV; Packer M; Zile MR; Desai AS; Rouleau JL; Swedberg K; Fonarow GC
JAMA Cardiol; 2018 Dec; 3(12):1226-1231. PubMed ID: 30484837
[TBL] [Abstract][Full Text] [Related]
15. Physicians' adherence to guideline-recommended medications in heart failure with reduced ejection fraction: data from the QUALIFY global survey.
Komajda M; Anker SD; Cowie MR; Filippatos GS; Mengelle B; Ponikowski P; Tavazzi L;
Eur J Heart Fail; 2016 May; 18(5):514-22. PubMed ID: 27095461
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin receptor/neprilysin inhibitor-a breakthrough in chronic heart failure therapy: summary of subanalysis on PARADIGM-HF trial findings.
Książczyk M; Lelonek M
Heart Fail Rev; 2020 May; 25(3):393-402. PubMed ID: 31713710
[TBL] [Abstract][Full Text] [Related]
17. The ABCs of managing systolic heart failure: Past, present, and future.
Okwuosa IS; Princewill O; Nwabueze C; Mathews L; Hsu S; Gilotra NA; Lewsey S; Blumenthal RS; Russell SD
Cleve Clin J Med; 2016 Oct; 83(10):753-765. PubMed ID: 27726827
[TBL] [Abstract][Full Text] [Related]
18. Contemporary Drug Treatment of Chronic Heart Failure With Reduced Ejection Fraction: The CHECK-HF Registry.
Brunner-La Rocca HP; Linssen GC; Smeele FJ; van Drimmelen AA; Schaafsma HJ; Westendorp PH; Rademaker PC; van de Kamp HJ; Hoes AW; Brugts JJ;
JACC Heart Fail; 2019 Jan; 7(1):13-21. PubMed ID: 30606482
[TBL] [Abstract][Full Text] [Related]
19. Alteration of medical therapy in patients with heart failure relative to change in symptom severity.
Ibrahim NE; Song Y; Cannon CP; Doros G; Russo P; Ponirakis A; Alexanian C; Januzzi JL
ESC Heart Fail; 2019 Oct; 6(5):1085-1087. PubMed ID: 31268222
[TBL] [Abstract][Full Text] [Related]
20. The renin-angiotensin-aldosterone system in heart failure for the non-specialist: the past, the present and the future.
Orsborne C; Chaggar PS; Shaw SM; Williams SG
Postgrad Med J; 2017 Jan; 93(1095):29-37. PubMed ID: 27671772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]